Business Description
Genxone SA
ISIN : PLGENXN00013
Share Class Description:
WAR:GX1: Ordinary SharesTotal Employee Number:
19Description
Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 24.65 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39.6 | |||||
3-Year FCF Growth Rate | -135.8 | |||||
3-Year Book Growth Rate | -23.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 18.08 | |||||
9-Day RSI | 32.72 | |||||
14-Day RSI | 39.61 | |||||
3-1 Month Momentum % | -8.95 | |||||
6-1 Month Momentum % | 38.17 | |||||
12-1 Month Momentum % | 1.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.17 | |||||
Quick Ratio | 7.73 | |||||
Cash Ratio | 6.77 | |||||
Days Inventory | 58.56 | |||||
Days Sales Outstanding | 35 | |||||
Days Payable | 37.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.84 | |||||
Operating Margin % | -89.24 | |||||
Net Margin % | -80.14 | |||||
EBITDA Margin % | -41.5 | |||||
FCF Margin % | -84.42 | |||||
OCF Margin % | -82.51 | |||||
ROE % | -21.21 | |||||
ROA % | -20.07 | |||||
ROIC % | -39.32 | |||||
3-Year ROIIC % | 92.03 | |||||
ROC (Joel Greenblatt) % | -604.14 | |||||
ROCE % | -21.18 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.8 | |||||
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 5.36 | |||||
EV-to-EBIT | -8.16 | |||||
EV-to-EBITDA | -15.73 | |||||
EV-to-Revenue | 6.53 | |||||
EV-to-FCF | -7.83 | |||||
Price-to-GF-Value | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 5.8 | |||||
| Price-to-Net-Cash | 7.19 | |||||
Earnings Yield (Greenblatt) % | -12.26 | |||||
FCF Yield % | -10.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genxone SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 2.407 | ||
| EPS (TTM) (zł) | -0.583 | ||
| Beta | -0.9208 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 50.08 | ||
| 14-Day RSI | 39.61 | ||
| 14-Day ATR (zł) | 0.218018 | ||
| 20-Day SMA (zł) | 5.971 | ||
| 12-1 Month Momentum % | 1.72 | ||
| 52-Week Range (zł) | 3.81 - 6.96 | ||
| Shares Outstanding (Mil) | 3.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genxone SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genxone SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genxone SA Frequently Asked Questions
What is Genxone SA(WAR:GX1)'s stock price today?
The current price of WAR:GX1 is zł5.68. The 52 week high of WAR:GX1 is zł6.96 and 52 week low is zł3.81.
When is next earnings date of Genxone SA(WAR:GX1)?
The next earnings date of Genxone SA(WAR:GX1) is .
Does Genxone SA(WAR:GX1) pay dividends? If so, how much?
Genxone SA(WAR:GX1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genxone SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers